Received: 27 November 2022
Accepted: 16 March 2023
First Online: 28 March 2023
: This study was approved by the China Ethics Committee of Registering Clinical Trials (Registration number: ChiECRCT20200200) and registered at Clinicaltrials.gov (NCT04477733). The study protocol followed the CONSORT guidelines. The study protocol was performed according to the relevant guidelines. Written informed consent was obtained from all patients.
: Not Applicable.
: The authors declare no competing interests.